A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

Chrissy Metz has opened up about her health journey, sharing her nuanced views on weight loss drugs such as Ozempic.

You’re reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday.